
Sign up to save your podcasts
Or


Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
805805 ratings
Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
See omnystudio.com/listener for privacy information.

78,681 Listeners

32,090 Listeners

6,772 Listeners

28,948 Listeners

16,196 Listeners

2,681 Listeners

404 Listeners

2,187 Listeners

1,981 Listeners

422 Listeners

12,226 Listeners

17,607 Listeners

970 Listeners

112,216 Listeners

197 Listeners

30 Listeners

10,185 Listeners

5 Listeners

58 Listeners

233 Listeners

233 Listeners

65 Listeners

76 Listeners

86 Listeners

402 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

1,146 Listeners

184 Listeners